Novartis | Passività Correnti



Current Liabilities Cambiamento Data
AbbVie USD 38.75B 4.31B 2024-12
Alcon AG USD 2.28B 178M 2024-12
Almirall EUR 274.01M 14.41M 2024-06
Amgen USD 23.01B 91M 2025-03
AstraZeneca USD 29.13B 1.26B 2025-03
Autolus Therapeutics Ltd 60.74M 8.27M 2024-12
Bayer EUR 28.95B 3.9B 2024-12
Biogen USD 5.3B 231.4M 2025-03
Bristol-Myers Squibb USD 24.07B 296M 2025-03
Eli Lilly USD 30.07B 1.69B 2025-03
Fresenius EUR 6.09B 2.19B 2024-12
Fresenius Medical Care EUR 5.66B 228.94M 2024-12
Galapagos EUR 437.04M 101.96M 2025-03
Genmab DKK 5.31B 723M 2024-12
Gilead Sciences USD 12B 279M 2024-12
GlaxoSmithKline GBP 20.83B 866M 2025-03
GRIFOLS EUR 2.16B 199.43M 2024-12
Hikma Pharmaceutical USD 1.38B 41M 2024-06
J&J USD 56.9B 6.58B 2025-03
Lonza CHF 3.58B 970M 2024-12
Merck EUR 11.29B 831M 2024-12
Merck USD 25.17B 3.25B 2025-03
Novartis USD 28.69B 560M 2024-12
Novartis USD 28.69B 560M 2024-12
Novo Nordisk 208.36B 20.45B 2024-09
Orion EUR 286.2M 12.8M 2025-03
Pfizer USD 36.45B 6.54B 2025-03
Philips EUR 8.15B 615M 2024-12
Recordati EUR 906.69M 19.47M 2024-09
Regeneron Pharmaceuticals USD 3.57B 2.13B 2025-03
Roche Holding CHF 27.02B 424M 2024-12
Sanofi 32.22B 3.06B 2025-03
UCB EUR 3.53B 731M 2024-12



Novartis Passività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.